Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

CRDFCRDF
Showing 3 of 14 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in CARDIFF ONCOLOGY INC

Yes. Qube Research & Technologies holds 125,550 shares of CRDF (Cardiff Oncology), worth $163,215, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$163,215

Current Shares

125,550

Total Value Change

+$63,771

Total Shares Change

+88,305

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
125,550
-
$163,2150.0%$1.30
31
2024-Q4
Exited
0
-100.0%
$00.0%$4.34
0
2024-Q3
Decreased
37,245
-8.4%
$99,4440.0%$2.67
0

Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used